Abstract
Chronic pelvic pain is a potentially devastating condition that affects many women with severe consequences. A multifaceted condition, chronic pelvic pain enjoys a diverse etiology, a myriad of treatments, and a correspondingly irregular response to therapy. The condition can be associated with severe physical dysfunction in relation to voiding, defecation, and sexual function. Although emphasis has been placed on surgical approaches to therapy, there is increasing interest in alternative therapies, particularly using the principles of the treatment of myofascial dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Steege JF, Metzger DA. Chronic Pelvic Pain, edn 1. Philadelphia: WB Saunders Company; 1998. The current standard for a comprehensive but readable text of a complex societal and medical problem.
Health Surveillance Alberta Health and Wellness EA: Chronic pain in Alberta: A Portrait from the 1996 National Population Health Survey and the 2001 Canadian Community Health Survey. 2003. http://www.health.gov.ab.ca/public/diseases/pdf/ChronicPainReport.pdf. Accessed May 1, 2004.
Mathias SD, Kupperman M, Lieberman RF, et al.: Chronic pelvic pain prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996, 87:321–328.
Olive DL, Pritts EA: The treatment of endometriosis: a review of the evidence. Ann N Y Acad Sci 2002, 955:360–372.
Schroeder AK, Diedrich K, Ludwig M: Medical management of endometriosis. Drugs 2004, 7:451–463.
Wenzyl R, Kiesel L, Huber JC, Wieser F: Endometriosis: a genetic disease. Drugs Today (Barc) 2003, 39:961–972.
Bischoff FZ, Simpson JL. Heritability and molecular genetic studies of endometriosis. Hum Reprod Update 2000, 6:37–44.
Barbieri RL: Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 1990, 162:565–567.
Sampson JA: Perforating hemorrhagic (chocolate) cysts of the ovary. Arch Surg 1921, 3:245–250.
Sampson JA: Ovarian hematomas of endometrial type (perforating hemorrhagic cysts of the ovary) and implantation adenomas of endometrial type. Boston Med Surg J 1922, 186:445.
Redwine DB: Was Sampson wrong? Fertil Steril 2002, 78:686–693.
Paul DW, Braun DP: Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004, 18:245–263.
Rier SE: The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 2002, 955:201–212.
Rier SE, Turner WE, Martin DC, et al.: Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol Sci 2001, 59:147–159.
De Felip E, Porpora MG, di Domenico A, et al.: Dioxin-like compounds and endometriosis: a study on Italian and Belgian women of reproductive age. Toxicol Lett 2004, 150:203–209.
Guo SW: The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest 2004, 57:157–173.
Simons DG: The nature of myofascial trigger points. Clin J Pain 1995, 11:83–84.
Gerwin RD: Neurobiology of the myofascial trigger point. Baillieres Clin Rheumatol 1994, 8:747–762.
Gerwin RD: Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep 2001, 5:412–420. Gerwin’s description of myofascial disorders is a helpful reference when applied to the pelvic musculature.
Travell JG, Simons DG: Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams and Wilkins; 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jarrell, J. Myofascial dysfunction in the pelvis. Current Science Inc 8, 452–456 (2004). https://doi.org/10.1007/s11916-004-0066-0
Issue Date:
DOI: https://doi.org/10.1007/s11916-004-0066-0